Cargando…

The Evolving Landscape of Biomarkers in Celiac Disease: Leading the Way to Clinical Development

Celiac disease is a common immune-mediated disease characterized by abnormal T-cell responses to gluten. For many patients, symptoms and intestinal damage can be controlled by a gluten-free diet, but, for some, this approach is not enough, and celiac disease progresses, with serious medical conseque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smithson, Glennda, Siegelman, Jenifer, Oki, Toshihiko, Maxwell, Joseph R., Leffler, Daniel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060282/ https://www.ncbi.nlm.nih.gov/pubmed/33897715 http://dx.doi.org/10.3389/fimmu.2021.665756

Ejemplares similares

Circulating miRNAs as Potential Biomarkers for Celiac Disease Development
por: Tan, Ineke L., et al.
Publicado: (2021)

Quantification of Celiac Disease Severity Using Video Capsule Endoscopy: A Comparison of Human Experts and Machine Learning Algorithms
por: Zammit, Stefania Chetcuti, et al.
Publicado: (2023)

Evolving Therapy for Celiac Disease
por: Yoosuf, Shakira, et al.
Publicado: (2019)

The Evolving Landscape of Cancer Stem Cells and Ways to Overcome Cancer Heterogeneity
por: Taniguchi, Hiroaki, et al.
Publicado: (2019)

The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma
por: Amin, Asim, et al.
Publicado: (2019)

The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer
por: Qiao, Xin-wei, et al.
Publicado: (2020)

Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren’s syndrome to facilitate their concerted migration
por: Blokland, Sofie L. M., et al.
Publicado: (2019)

Cancer in first-degree relatives of people with celiac disease
por: Emilsson, Louise, et al.
Publicado: (2016)

Can Celiac Disease Be Prevented?
por: Auricchio, Renata, et al.
Publicado: (2021)

Paving the Way Towards Universal Chimeric Antigen Receptor Therapy in Cancer Treatment: Current Landscape and Progress
por: Zhang, Yixi, et al.
Publicado: (2020)

Enterovirus Infections Are Associated With the Development of Celiac Disease in a Birth Cohort Study
por: Oikarinen, Maarit, et al.
Publicado: (2021)

Celiac Disease: Diagnostic Standards and Dilemmas
por: Kaswala, Dharmesh H., et al.
Publicado: (2015)

The present and the future in the diagnosis and management of celiac disease
por: Castillo, Natalia E., et al.
Publicado: (2015)

Recent Advances in Celiac Disease from TTG to Gluten in Pee
por: Silvester, J A, et al.
Publicado: (2015)

The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer
por: Taieb, Julien, et al.
Publicado: (2019)

The intestinal B-cell response in celiac disease
por: Mesin, Luka, et al.
Publicado: (2012)

To Be or Not to Be a Pathogen: Candida albicans and Celiac Disease
por: Renga, Giorgia, et al.
Publicado: (2019)

Intervention strategies in early childhood to prevent celiac disease—a mini-review
por: Andrén Aronsson, Carin, et al.
Publicado: (2023)

Gut Microbiota in Celiac Disease: Is There Any Role for Probiotics?
por: Pecora, Francesco, et al.
Publicado: (2020)

The importance of biomarker development for monitoring type 1 diabetes progression rate and therapeutic responsiveness
por: Fyvie, Maxwell J., et al.
Publicado: (2023)

TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy
por: Skeate, Joseph G., et al.
Publicado: (2020)

Revealing the Immune Infiltration Landscape and Identifying Diagnostic Biomarkers for Lumbar Disc Herniation
por: Wang, Linbang, et al.
Publicado: (2021)

The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer
por: Xu, Yufei, et al.
Publicado: (2022)

Challenges in the Evolving CME Landscape
por: Gillgrass, Darren
Publicado: (2020)

Cervical screening: the evolving landscape
por: Davies-Oliveira, Jennifer C, et al.
Publicado: (2022)

Prevention and control of HPV and HPV-related cancers in France: the evolving landscape and the way forward – a meeting report
por: Waheed, Dur-e-Nayab, et al.
Publicado: (2023)

Prediction of celiac disease associated epitopes and motifs in a protein
por: Tomer, Ritu, et al.
Publicado: (2023)

Intestinal and blood lymphograms as new diagnostic tests for celiac disease
por: Roy, Garbiñe, et al.
Publicado: (2023)

Celiac disease: a comprehensive current review
por: Caio, Giacomo, et al.
Publicado: (2019)

Editorial: Evolving Mechanisms of Disease Tolerance
por: King, Irah L., et al.
Publicado: (2019)

The evolving landscape of predictive biomarkers in immuno‐oncology with a focus on spatial technologies
por: Sadeghi Rad, Habib, et al.
Publicado: (2020)

Editorial: The Evolving Landscape, Clinical Implications, and Future Perspective of Biomarkers in Gastrointestinal Cancers
por: Tsai, Hsiang-Lin, et al.
Publicado: (2022)

The Metabolic Landscape of Thymic T Cell Development In Vivo and In Vitro
por: Sun, Victoria, et al.
Publicado: (2021)

Primate liver tissue substrate in indirect immunofluorescence diagnostics for patients with dermatitis herpetiformis and celiac disease
por: Schauer, Franziska, et al.
Publicado: (2023)

The lead leads the way
por: Borges, S., et al.
Publicado: (2021)

The lead leads the way
por: Borges, S., et al.
Publicado: (2021)

Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint Therapy
por: Falade, Ayo S., et al.
Publicado: (2022)

Measuring Serum Vedolizumab and Vedolizumab Antibodies: Comparison of Commercial Assays with the Vedolizumab Clinical Development Assay
por: Vande Casteele, Niels, et al.
Publicado: (2023)

Evolving Strategies for Cancer and Autoimmunity: Back to the Future
por: Lane, Peter J. L., et al.
Publicado: (2014)

The Evolving Role of TRAFs in Mediating Inflammatory Responses
por: Dhillon, Bipandeep, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qv3vfa2dl1ok32hrogpq5b09hb